We are live on ! Find out more
NUVB.WS

Nuvation Bio Inc Warrants
NUVB.WS

Delisted

NUVB.WS was delisted on the 10th of February, 2026.

Back to rankings

20 hedge funds and large institutions have $2.34M invested in Nuvation Bio Inc Warrants in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 20 → 20 (0)

0.01% less ownership

Funds ownership: 1.81% → 1.81% (-0.01%)

17% less capital invested

Capital invested by funds: $2.81M → $2.34M (-$473K)

67% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 3

Holders
20
Holders Change
–
Holders Change %
0%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$40

Top Sellers

Rank Fund Capital Flow
1
IP
Intellectus Partners
California
-$940
2
UBS Group
UBS Group
Switzerland
-$222
3
Barclays
Barclays
United Kingdom
-$37
Name Holding Trade Value Shares
Change 		Change in
Stake
EC
1
EcoR1 Capital
California
$1.85M – – –
6CM
2
683 Capital Management
New York
$121K – – –
HCM
3
Highbridge Capital Management
New York
$57K – – –
Adage Capital Partners
4
Adage Capital Partners
Massachusetts
$38.5K – – –
BC
5
Boxer Capital
California
$38.5K – – –
Franklin Resources
6
Franklin Resources
California
$38.5K – – –
CCA
7
Castle Creek Arbitrage
Colorado
$28.8K – – –
DM
8
Deerfield Management
New York
$24.1K – – –
BlackRock
9
BlackRock
New York
$22.5K – – –
RSCM
10
Rock Springs Capital Management
Maryland
$19.4K – – –
SB
11
Samsara BioCapital
California
$19.3K – – –
APM
12
Avidity Partners Management
Texas
$14.4K – – –
GC
13
Greenlight Capital
New York
$14.4K – – –
ACP
14
Acuta Capital Partners
California
$13.1K – – –
Citadel Advisors
15
Citadel Advisors
Florida
$10.7K +$40 +296 +0.4%
LGM
16
Logos Global Management
California
$9.63K – – –
Victory Capital Management
17
Victory Capital Management
Texas
$9.26K – – –
CC
18
Clearline Capital
New York
$4.81K – – –
IP
19
Intellectus Partners
California
$1.87K -$940 -7,037 -35%
Barclays
20
Barclays
United Kingdom
$237 -$37 -280 -15%
UBS Group
21
UBS Group
Switzerland
$71 -$222 -1,660 -77%

NUVB.WS Hedge Fund Activity: Q4 2022 in Review

20 of the 6,223 institutional investors tracked by Wall St. Rank reported a position in Nuvation Bio Inc Warrants (NUVB.WS) for Q4 2022, worth a combined $2.34M — down 17% from $2.81M a quarter earlier.

Fund positioning in NUVB.WS was balanced in Q4 2022: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 3 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $40. The largest seller was Intellectus Partners, cutting an estimated $940.

  • 20 institutional investors held Nuvation Bio Inc Warrants (NUVB.WS) as of Q4 2022, unchanged from Q3 2022.
  • Funds reported $2.34M of Nuvation Bio Inc Warrants stock for Q4 2022, down 17% quarter-over-quarter.
  • 0 funds opened new Nuvation Bio Inc Warrants positions in Q4 2022 and 0 closed out.
  • The largest Nuvation Bio Inc Warrants buyer in Q4 2022 was Citadel Advisors, an estimated $40 added.
  • The largest Nuvation Bio Inc Warrants seller in Q4 2022 was Intellectus Partners, an estimated $940 sold.

Based on aggregated 13F filings for Q4 2022.